Shots:

• The US FDA’s Center for Devices and Radiological Health has granted breakthrough device designation for Shreis’ Cytotron- invented by Dr. Rajah Vijay Kumar in Bengaluru- India- indicated for the treatment of solid tumors of the breast- liver- and pancreas
• Shreis is actively collaborating with other companies for the clinical studies of Cytotron in the proposed indications and plans to submit a request for BT designation in adult and pediatric brain tumors- lung cancer- and other life-limiting diseases
•  The Cytotron is intended to cause degeneration of uncontrolled growth of tissues- act by selectively targeting and enabling tissue apoptosis- thus indicated to treat protein linked regenerating disorders like a neoplastic disease

Click here to­ read full press release/ article | Ref: PRNewswire | Image: Your story